Genetic Mapping for Bipolar Disorder and Schizophrenia - Cardenas, Samantha
16,99 €
inkl. MwSt.

Versandfertig in über 4 Wochen
  • Broschiertes Buch

Bipolar Disorder and Schizophrenia afflict approximately 2% of the human population, more than 12,400,000 people. When family members, co-workers, and care-givers are factored in, more than 10% of the population is directly impacted by these medical conditions. Finding a way to reduce the severity of the symptoms or cure these diseases would positively impact a large number of people. This paper defines and differentiates between these two similar-but-different maladies, and explores both the traditional courses of treatment as well as the most current research with potential to help combat…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Bipolar Disorder and Schizophrenia afflict approximately 2% of the human population, more than 12,400,000 people. When family members, co-workers, and care-givers are factored in, more than 10% of the population is directly impacted by these medical conditions. Finding a way to reduce the severity of the symptoms or cure these diseases would positively impact a large number of people. This paper defines and differentiates between these two similar-but-different maladies, and explores both the traditional courses of treatment as well as the most current research with potential to help combat these diseases especially genetic mapping with the use of neuroimaging. Because genetic mapping has been successfully used to treat cancers, applying this technique to neurological disorders is the next logical step to take.
Autorenporträt
Samantha M. Cardenas, BA: Studied Chemistry with a concentration in Premedical Chemistry, a minor in Psychology, and graduated cum laude at Eastern Kentucky University in Richmond, KY. Dr. Jerome May, Eastern Kentucky University, was the mentor for this thesis.